Neurologic Music Therapy for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
Parkinson's Disease (PD) is defined by characteristic motor symptoms including slow movements, small movements, difficulty with movement initiation and disruptions in timing. Besides gross motor symptoms, fine motor impairments in PD cause difficulties with everyday tasks such as writing, self-care, and fine object manipulation. These activity limitations can lead to disability, social isolation, and a reduced quality of life. In a series of breakthrough studies Michael Thaut and colleagues developed Neurologic Music Therapy (NMT) and found it can address many gross motor impairments and improve gait and balance. Other music therapies such as Music-supported Therapy (MST) have proven motor benefits in stroke patients through movement exercises with musical instruments. However, the pathological basal ganglia (BG) in PD brains leads to a reduced supply of those internally generated movements. In contrast, externally cued movements (eg. via a beat or a rhythm) during NMT sessions are instantaneously entrained to the period of a rhythmic stimulus possibly without involvement of the BG. The underlying idea is that rhythm is the essential component relating music specifically to motor behavior. The mechanism of action is called "rhythmic entrainment" where one system's motion or signal frequency entrains the frequency of another system. The effect of NMT on fine motor function has not been investigated yet. Music activities are important in the lives of many older adults. Notably, the use of music has been associated with increased well-being for older adults, as it fosters social connection and mood regulation. Furthermore, many musical activities have limited physical demands, making them attainable for individuals who are living with mobility impairments or other physical restrictions. Based on the literature and the investigators preliminary studies, the investigators propose to test the efficacy of Neurologic Music Therapy in comparison to Music Supported Therapy and Occupational Therapy (OT) as standard of care on adults in the Parkinson's spectrum. The investigators have defined a working plan using different musical instruments and growing tempo to specifically improve fine motor movements.
Will I have to stop taking my current medications?
The trial requires that your medication be stable for at least 30 days, so you should not change your current medications before or during the study.
Is Neurologic Music Therapy safe for humans?
How is Neurologic Music Therapy different from other treatments for Parkinson's disease?
Neurologic Music Therapy (NMT) is unique because it uses music and rhythm to improve movement and balance in Parkinson's patients, relying on neural pathways that are not affected by the disease. Unlike medications or surgeries, NMT is a non-drug approach that can enhance gait and motor functions through techniques like rhythmic auditory stimulation, which uses external rhythmic cues to aid walking.14567
What data supports the effectiveness of the treatment Neurologic Music Therapy for Parkinson's Disease?
Research shows that Neurologic Music Therapy, particularly using rhythmic auditory stimulation, can significantly improve walking and balance in Parkinson's patients, reducing their risk of falls. Additionally, music therapy has been found to help with motor and emotional functions, enhancing overall quality of life for those with Parkinson's disease.14578
Who Is on the Research Team?
Isabelle Buard, PhD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
Adults aged 45-85 with Parkinson's Disease, experiencing fine motor impairments, and stable on medication for at least a month can join. Excluded are those with other forms of parkinsonism, inability to move fingers or hands, involvement in other music therapy studies, lack of insurance coverage for Occupational Therapy, advanced Parkinson's (stage 4+), metal implants affecting MEG/MRI data or safety concerns, and dementia.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Neurologic Music Therapy, Music Supported Therapy, or Occupational Therapy for 5 weeks to improve fine motor movements
Waitlist Control
Participants in the waitlist-control condition do not receive immediate treatment and wait for 5 weeks before being randomized to receive NMT, MST, or OT
Follow-up
Participants are monitored for changes in motor function and quality of life after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Music Supported Therapy
- Neurologic Music Therapy
- Occupational Therapy
Neurologic Music Therapy is already approved in United States, Canada, European Union for the following indications:
- Rehabilitation for Parkinson's disease
- Stroke rehabilitation
- Traumatic brain injury rehabilitation
- Rehabilitation for Parkinson's disease
- Stroke rehabilitation
- Traumatic brain injury rehabilitation
- Rehabilitation for Parkinson's disease
- Stroke rehabilitation
- Traumatic brain injury rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator